Shift in Managing Cardiovascular Disease
Abstract
The escalating global burden of cardiovascular diseases (CVDs) is worrisome. The editorial emphasizes the critical role of individualized cardiovascular risk management, addressing controversies in cholesterol management and recognizing ethnicity-specific risk factors particularly considering genetic variations in Asian populations. It also delves into, creating awareness of hypertension and prevalent CVD including Ischaemic heart disease (IHD) and Heart failure (HF), their prevalence, and shifts in current management to tackle them. World Heart Day 2023, themed “Use Heart, Know Heart”, emphasizes the significance of knowing our heart and heart health for a healthy life.
Conflict of Interest: Aristo Pharmaceuticals Private Limited, India
Source of Support: None declared
References
2. Loh JP, Poh KK. Changes in the practice of cardiology: therapies at the forefront of science. Singapore medical journal. 2016 Jul;57(7):344.
3. Kulkarni A, Mancini GJ, Deedwania PC, Patel J. South Asian cardiovascular health: lessons learned from the national lipid association scientific statement. J Am Coll
Cardiol. 2021:2021.